Metoprolol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Metoprolol and local guidelines before prescribing.
Mechanism
Cardioselective beta-1 blocker.
Uses
Angina, hypertension, heart failure, post-MI, arrhythmia, migraine prophylaxis.
Dosing
- Metoprolol: 50–100 mg two to three times daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina
Side effects
Bradycardia, fatigue, cold extremities, bronchospasm, sleep disturbance.
Interactions
Verapamil and diltiazem (heart block); clonidine rebound; insulin masks hypoglycaemia.
Contraindications and cautions
Asthma, heart block, severe bradycardia, cardiogenic shock
Monitoring
Pulse, BP
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in liver impairment
Overdose and reversal
Atropine, glucagon
Special advice
Do not stop abruptly; avoid in severe asthma and heart block.
More from the textbook: uses, cautions and other points
- Beta-1 | Heart - faster rate (chronotropy), stronger contraction (inotropy), faster AV conduction; kidney - renin release | Agonist: dobutamine. Blockers: bisoprolol, metoprolol, atenolol
Cardiology: Anatomy Physiology and Pharmacology - Cardioselective (beta-1) - bisoprolol, metoprolol, atenolol, nebivolol.
Cardiology: Anatomy Physiology and Pharmacology - Beta-blocker (e.g. bisoprolol orally, or IV metoprolol in increments) or rate-limiting calcium channel blocker (diltiazem, verapamil) - avoid calcium channel blockers in heart failure with reduced EF.
Cardiology: Cardiology Emergencies - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers - Treatment before delivery: Beta blocker (e.g. metoprolol), loop diuretic for congestion, hydralazine and nitrates for afterload reduction; avoid ACE inhibitors, ARBs, ARNIs, MRAs and SGLT2 inhibitors. Urgent pregnancy heart team input for timing and mode of delivery.
Cardiology: Cardiomyopathies › 3.42 Peripartum Cardiomyopathy (PPCM) - … postpartum and breastfeeding, is breathless with an LVEF of 28%. Answer: Peripartum cardiomyopathy - HFrEF therapy compatible with breastfeeding (e.g. enalapril, metoprolol), diuretics, consider bromocriptine with anticoagulation (stops lactation), wearable defibrillator, and counselling against further pregnancy unless EF …
Cardiology: Cardiomyopathies › 3.59 Exam-style Scenarios
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (4 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Heart Failure (1 mention)
- Cardiology: Cardiomyopathies (2 mentions)
- Integrated cardiology chapter (4 mentions)